The University of Chicago Header Logo

Connection

Mitchell C. Posner to Carcinoma, Squamous Cell

Back to Details
This is a "connection" page, showing publications Mitchell C. Posner has written about Carcinoma, Squamous Cell.
Mitchell C. Posner
Connection Strength
1.321
Carcinoma, Squamous Cell
  1. The Italian Collaborative Group sets a standard for the treatment of locally advanced head and neck cancer. Ann Oncol. 2017 09 01; 28(9):2051-2054.
    View in: PubMed
    Score: 0.371
  2. Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck. Ann Oncol. 2014 Aug; 25(8):1667-8.
    View in: PubMed
    Score: 0.296
  3. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):599-604.
    View in: PubMed
    Score: 0.124
  4. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am. 1998 Jul-Aug; 4(4):237-46.
    View in: PubMed
    Score: 0.098
  5. Role of nutrition support during induction chemoradiation therapy in esophageal cancer. JPEN J Parenter Enteral Nutr. 1998 Jan-Feb; 22(1):18-21.
    View in: PubMed
    Score: 0.095
  6. Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement. Ann Surg. 2016 Feb; 263(2):286-91.
    View in: PubMed
    Score: 0.083
  7. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction. Med Oncol. 2011 Dec; 28 Suppl 1:S152-61.
    View in: PubMed
    Score: 0.057
  8. Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma. Cancer Chemother Pharmacol. 2005 Sep; 56(3):317-21.
    View in: PubMed
    Score: 0.040
  9. Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma. Arch Surg. 2001 Jul; 136(7):737-42; discussion 743.
    View in: PubMed
    Score: 0.030
  10. Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer. J Clin Oncol. 2001 Jan 15; 19(2):289-98.
    View in: PubMed
    Score: 0.029
  11. Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res. 1999 Aug 15; 59(16):4142-7.
    View in: PubMed
    Score: 0.027
  12. Risk factors for squamous cell carcinoma of the oesophagus. Br J Surg. 1996 Sep; 83(9):1174-85.
    View in: PubMed
    Score: 0.022
  13. Concurrent cis-platinum and radiation with or without surgery for advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 1994 Dec 01; 30(5):1043-50.
    View in: PubMed
    Score: 0.019
  14. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Res. 2013 Jan 01; 73(1):184-94.
    View in: PubMed
    Score: 0.017
  15. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep. 1981 Sep-Oct; 65(9-10):787-91.
    View in: PubMed
    Score: 0.008
  16. Efficacy of cisplatin, 5-fluorouracil, and paclitaxel regimen for carcinoma of the esophagus. Semin Oncol. 1997 Dec; 24(6 Suppl 19):S19-89-S19-92.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.